Fezolinetant is a nonhormonal medication designed to treat moderate-to-severe vasomotor symptoms (hot flashes and night sweats) linked to menopause. It works by blocking neurokinin B activity in the brain, helping regulate body temperature. This oral therapy offers an option for women who cannot or prefer not to use hormone therapy, providing relief without estrogen-related risks.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends